Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2020 | 04-2020 | 01-2020 | 10-2019 | 07-2019 | |
| Sales | 0 | 0 | 0 | 2 | 0 |
| Cost of Goods | 0 | N/A | 0 | 18 | 24 |
| Gross Profit | 0 | N/A | 0 | -15 | -24 |
| Operating Expenses | 70 | 45 | 37 | -10 | 15 |
| Operating Income | -70 | -45 | -37 | -5 | -39 |
| Interest Expense | 2 | 2 | N/A | N/A | N/A |
| Other Income | 0 | 0 | 0 | -21 | 0 |
| Pre-tax Income | -71 | -47 | -38 | -27 | -39 |
| Net Income Continuous | -71 | -47 | -38 | -27 | -39 |
| Net Income | $-71 | $-47 | $-38 | $-27 | $-39 |
| EBITDA(a) | $-70 | $-45 | $-37 | $-5 | $-39 |